LAC 48:I.13609. Training

A. Training Content. Prior to independently dispensing and/or administering HIV prevention therapies to a patient pursuant to R.S. 37:1218.2, the pharmacist shall successfully complete a training program approved by the Accreditation Council for Pharmacy Education (ACPE). This training may take place as a stand-alone course or as part of an equivalent curriculum-based training program offered by an ACPE-accredited school of pharmacy. At a minimum, the training shall consist of the criteria set forth in Subsection A.1 of this Section, and the pharmacist must also complete the training required to administer medications in the state of Louisiana adopted by the LABP as set forth in Subsection A.2 of this Section. 1. Training Program. A pharmacist must complete a training program specific to the use of HIV pre-exposure and post-exposure prophylaxis (PrEP/PEP) that includes instruction covering, at a minimum, the following areas: a. CDC Guidelines for PrEP/PEP; b. screening for HIV and sexually transmitted infections (STIs) and laboratory testing to determine PrEP/PEP eligibility; c. pharmacology, safety, efficacy, drug-drug interactions, and monitoring parameters for HIV medications used for PrEP/PEP; d. strategies for serving historically marginalized patient populations and sexual assault survivors or related trauma-informed care; e. culturally sensitive patient counseling information; and f. strategies to access manufacturer and government financial assistance programs for HIV PrEP/PEP. 2. Administration of Medications Training. A pharmacist shall complete all training requirements required by the LABP and the State of Louisiana in LAC 46.LIII. prior to administering any medication. 3. Continuing Education Requirement. A pharmacist shall complete at least one hour of continuing education in the subject of HIV prevention every two years, to be reported to the LABP as per continuing education requirements. B. Training Certification and Documentation 1. A pharmacist shall maintain documentation of their successful completion of the required training as set forth in Section 13609 of this Chapter for a period of at least two years following any patient interactions involving dispensing and/or administering HIV prevention medications that are subject to this rule per LAC 46.LIII.1121. Documentation maintained pursuant to this subsection must be made available upon request of the LABP. 2. Training obtained as part of an equivalent curriculum-based training program can be documented by written certification from a member of the educational institution or program from which the licensee graduated stating that the training is included within the institution’s curriculum required for graduation at the time the pharmacist graduated, or within the coursework that the pharmacist completed. Documentation maintained pursuant to this subsection must be made available upon request of the LABP. 3. Sanctions a. The failure of a pharmacist to obtain and maintain the education, training, and continuing competency described in this Section prior to administering medications to patients or supervising other pharmacy personnel administering medications to patients shall constitute a violation of R.S. 37:1218.2 and R.S. 37:1241(A)(3) and shall subject the pharmacist to disciplinary action by the LABP. b. The failure of a pharmacist to provide documentation of their education, training, and continuing competency to administer medications when requested by the board shall constitute a violation of R.S. 37:1218.2 and R.S. 37:1241(A)(22) and shall subject the pharmacist to disciplinary action by the LABP.